Pituitary adenoma (PA) is a common intracranial neoplasm that impacts on human health through interfering hypothalamus-pituitary-target organ axis systems. The development of proteomics gives great promises in the clarification of molecular mechanisms of a PA and discovery of effective biomarkers for prediction, prevention, early-stage diagnosis, and treatment for a PA. A great progress in the ...

This Symposium is sponsored by: Ruedi Aebersold, ETH Zurich Gary Bader, CCBR, University of Toronto Eleftherios Diamandis, University of Toronto Bruno Domon, Luxembourg Clinical Proteomics Center Andrew Emili, University of Toronto Albert Heck, University of Utrecht Lynn Megeney, Ottawa Hospital Research Institute Peipei Ping, University of California at Los Angeles Juri Rappsilber, University ...